"Minimally invasive therapies are reshaping the treatment landscape for structural heart disease, particularly for older or medically complex patients"
India, Sept. 24 -- image credit- freepik
Tricuspid regurgitation has long been labelled the "forgotten valve disease". What has historically kept TR out of mainstream cardiovascular discussions, and what factors are now driving its emergence as a major clinical priority?
Dr Saibal Kar- For many years, tricuspid regurgitation was seen largely as a secondary consequence of other heart conditions, particularly diseases affecting the left side of the heart. Its symptoms can also be subtle and develop gradually-fatigue, breathlessness or swelling, for example-which means patients may adapt to them or attribute them to ageing or other health issues. Historically, limited treatment options for patients at high surgical risk also contributed to...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.